3 Companies Rising on Good News for Friday 24th February 2023
Episode 1210, Feb 24, 2023, 09:36 AM
3 Companies Rising on Good News for Friday 24th February 2023
1. Jupiter Fund Mgmt #JUP - Results for the year ended 31 December 2022
Underlying profit before tax was £77.6m (2021: £216.7m).
Matthew Beesley, Chief Executive, commented:
"We have seen notable success and momentum in the institutional channel over the year, with net positive flows at record levels of £2.0bn, as our investment in this area has begun to deliver results"
2. Avation #AVAP - PRE RESULTS TRADING UPDATE
Due to a combination of factors such as lower than anticipated aircraft transition costs, lower administration and legal costs, improvements in finance income, recognition of gain on an investment in a listed airline and other variances, the Company expects its financial performance for the full year ending 30 June 2023 to be significantly ahead of market expectations.
3. Belluscura #BELL - Belluscura POC now marketed through GoodRx®
Belluscura announces that the X-PLOR portable oxygen concentrator ("POC") is now marketed in the US through GoodRx, Inc. www.goodrx.com. The X-PLOR will be the first medical device in its field marketed by GoodRx, Inc.
GoodRx, Inc (Nasdaq: GDRX) is a leading digital healthcare platform that makes healthcare affordable and convenient for all Americans.
1. Jupiter Fund Mgmt #JUP - Results for the year ended 31 December 2022
Underlying profit before tax was £77.6m (2021: £216.7m).
Matthew Beesley, Chief Executive, commented:
"We have seen notable success and momentum in the institutional channel over the year, with net positive flows at record levels of £2.0bn, as our investment in this area has begun to deliver results"
2. Avation #AVAP - PRE RESULTS TRADING UPDATE
Due to a combination of factors such as lower than anticipated aircraft transition costs, lower administration and legal costs, improvements in finance income, recognition of gain on an investment in a listed airline and other variances, the Company expects its financial performance for the full year ending 30 June 2023 to be significantly ahead of market expectations.
3. Belluscura #BELL - Belluscura POC now marketed through GoodRx®
Belluscura announces that the X-PLOR portable oxygen concentrator ("POC") is now marketed in the US through GoodRx, Inc. www.goodrx.com. The X-PLOR will be the first medical device in its field marketed by GoodRx, Inc.
GoodRx, Inc (Nasdaq: GDRX) is a leading digital healthcare platform that makes healthcare affordable and convenient for all Americans.